Startups
Vertex Pharmaceuticals
Team
 Stephen ChambersDirector of Gene Expression |
Investments
| $47M2021-03-23 |  Meatable | S32, GV, Vertex Pharmaceuticals, BlueYard Capital, Gates Foundation, Humboldt Fund, Section 32 |
Startups
| Stephen ChambersDirector of Gene Expression |
| $47M2021-03-23 | Meatable | S32, GV, Vertex Pharmaceuticals, BlueYard Capital, Gates Foundation, Humboldt Fund, Section 32 |